This document provides an overview of diabetic ketoacidosis (DKA). It begins with definitions of diabetes mellitus and discusses the types, causes, epidemiology, physiology, pathophysiology, clinical presentation, diagnosis, complications, and treatment of DKA. Key points include that DKA is caused by absolute or relative insulin deficiency, which leads to metabolic derangements including dehydration, electrolyte imbalances, and ketosis. Presenting symptoms range from nausea and vomiting to altered mental status. Treatment involves fluid resuscitation and insulin administration to resolve the metabolic abnormalities.
This webinar is organized by MyICID and Institute for Clinical Research (ICR), NIH, Ministry of Health in conjunction with Neglected Tropical Disease Day 2022. The purpose of this webinar is to refresh and update our knowledge on Dengue fever, which has been overshadowed by COVID-19 since the beginning of the pandemic.
Presenter: Dr Yasmin Mohamed Gani, Infectious Disease Physician at Hospital Sungai Buloh, Malaysia.
#dengue #WorldNTDDay #BeatNTDs #BestScienceforAll
Diabetes mellitus (DM) is a common, chronic, metabolic syndrome characterized by hyperglycemia as a cardinal biochemical feature. The major forms of diabetes are classified according to those caused by deficiency of insulin secretion due to pancreatic β-cell damage (type 1 DM, or T1DM) and those that are a consequence of insulin resistance occurring at the level of skeletal muscle, liver, and adipose tissue, with various degrees of β-cell impairment (type 2 DM, or T2DM). T1DM is the most common endocrine-metabolic disorder of childhood and adolescence, with important consequences for physical and emotional development. Individuals with T1DM confront serious lifestyle alterations that include an absolute daily requirement for exogenous insulin, the need to monitor their own glucose level, and the need to pay attention to dietary intake. Morbidity and mortality stem from acute metabolic derangements and from long-term complications (usually in adulthood) that affect small and large vessels resulting in retinopathy, nephropathy, neuropathy, ischemic heart disease, and arterial obstruction with gangrene of the extremities. The acute clinical manifestations are due to hypoinsulinemic hyperglycemic ketoacidosis. Autoimmune mechanisms are factors in the genesis of T1DM; the long-term complications are related to metabolic disturbances (hyperglycemia).
Type 1 Diabetes Mellitus
Formerly called insulin-dependent diabetes mellitus (IDDM) or juvenile diabetes, T1DM is characterized by low or absent levels of endogenously produced insulin and dependence on exogenous insulin to prevent development of ketoacidosis, an acute life-threatening complication of T1DM. The natural history includes 4 distinct stages: (1) preclinical β-cell autoimmunity with progressive defect of insulin secretion, (2) onset of clinical diabetes, (3) transient remission “honeymoon period,” and (4) established diabetes associated with acute and chronic complications and decreased life expectancy. The onset occurs predominantly in childhood, with median age of 7-15 yr, but it may present at any age. The incidence of T1DM has steadily increased in many parts of the world, including Europe and the USA. T1DM is characterized by autoimmune destruction of pancreatic islet β cells. Both genetic susceptibility and environmental factors contribute to the pathogenesis. Susceptibility to T1DM is genetically controlled by alleles of the major histocompatibility complex (MHC) class II genes expressing human leukocyte antigens (HLAs). It is also associated with autoantibodies to islet cell cytoplasm (ICA), insulin (IAA), antibodies to glutamic acid decarboxylase (GADA or GAD65), and ICA512 (IA2). T1DM is associated with other autoimmune diseases such as thyroiditis, celiac disease, multiple sclerosis, and Addison disease. There is some suggestion that high dietary intake of omega-3 polyunsaturated fatty acids and vitamin D supplementation in early childhood decreases the incidence of autoi
This webinar is organized by MyICID and Institute for Clinical Research (ICR), NIH, Ministry of Health in conjunction with Neglected Tropical Disease Day 2022. The purpose of this webinar is to refresh and update our knowledge on Dengue fever, which has been overshadowed by COVID-19 since the beginning of the pandemic.
Presenter: Dr Yasmin Mohamed Gani, Infectious Disease Physician at Hospital Sungai Buloh, Malaysia.
#dengue #WorldNTDDay #BeatNTDs #BestScienceforAll
Diabetes mellitus (DM) is a common, chronic, metabolic syndrome characterized by hyperglycemia as a cardinal biochemical feature. The major forms of diabetes are classified according to those caused by deficiency of insulin secretion due to pancreatic β-cell damage (type 1 DM, or T1DM) and those that are a consequence of insulin resistance occurring at the level of skeletal muscle, liver, and adipose tissue, with various degrees of β-cell impairment (type 2 DM, or T2DM). T1DM is the most common endocrine-metabolic disorder of childhood and adolescence, with important consequences for physical and emotional development. Individuals with T1DM confront serious lifestyle alterations that include an absolute daily requirement for exogenous insulin, the need to monitor their own glucose level, and the need to pay attention to dietary intake. Morbidity and mortality stem from acute metabolic derangements and from long-term complications (usually in adulthood) that affect small and large vessels resulting in retinopathy, nephropathy, neuropathy, ischemic heart disease, and arterial obstruction with gangrene of the extremities. The acute clinical manifestations are due to hypoinsulinemic hyperglycemic ketoacidosis. Autoimmune mechanisms are factors in the genesis of T1DM; the long-term complications are related to metabolic disturbances (hyperglycemia).
Type 1 Diabetes Mellitus
Formerly called insulin-dependent diabetes mellitus (IDDM) or juvenile diabetes, T1DM is characterized by low or absent levels of endogenously produced insulin and dependence on exogenous insulin to prevent development of ketoacidosis, an acute life-threatening complication of T1DM. The natural history includes 4 distinct stages: (1) preclinical β-cell autoimmunity with progressive defect of insulin secretion, (2) onset of clinical diabetes, (3) transient remission “honeymoon period,” and (4) established diabetes associated with acute and chronic complications and decreased life expectancy. The onset occurs predominantly in childhood, with median age of 7-15 yr, but it may present at any age. The incidence of T1DM has steadily increased in many parts of the world, including Europe and the USA. T1DM is characterized by autoimmune destruction of pancreatic islet β cells. Both genetic susceptibility and environmental factors contribute to the pathogenesis. Susceptibility to T1DM is genetically controlled by alleles of the major histocompatibility complex (MHC) class II genes expressing human leukocyte antigens (HLAs). It is also associated with autoantibodies to islet cell cytoplasm (ICA), insulin (IAA), antibodies to glutamic acid decarboxylase (GADA or GAD65), and ICA512 (IA2). T1DM is associated with other autoimmune diseases such as thyroiditis, celiac disease, multiple sclerosis, and Addison disease. There is some suggestion that high dietary intake of omega-3 polyunsaturated fatty acids and vitamin D supplementation in early childhood decreases the incidence of autoi
Diabetic ketoacidosis (DKA) is an acute, major, life-threatening complication of diabetes that mainly occurs in patients with type 1 diabetes, but it is not uncommon in some patients with type 2 diabetes. This condition is a complex disordered metabolic state characterized by hyperglycemia, ketoacidosis, and ketonuria.
Diabetic ketoacidosis (DKA) is an acute, major, life-threatening complication of diabetes that mainly occurs in patients with type 1 diabetes, but it is not uncommon in some patients with type 2 diabetes. This condition is a complex disordered metabolic state characterized by hyperglycemia, ketoacidosis, and ketonuria.
to download this presentation from this link
https://mohmmed-ink.blogspot.com/2020/11/diabetic-ketoacidosis.html
Diabetic Ketoacidosis, diabetus type 1 complection. diagnosisi and managment
this power point descripe diabetic ketoacidosis in pediatric age group .. we talk about the risk of it .. management specially (fluid management) as case study .. complications and the treatment of brain oedema .. i hope to be auseful one .. enjoy
A small prayer, with big rewards. A deeper look into a man named Jabez & his little prayer. And how you too can reap all the blessings God has prepared for you, What are you waiting for?.
This presentation was present by my friend during emergency posting seminar with Dr.Mohd. Kamal Mohd. Arshad. I upload this ppt here for all of us and my own reference too. Good luck in your life.
Diabetes is a disease chronic disease which affects global population from long time. This review is an update on unknown complications, causes, treatment modalities of this disease. This article also provides a summary on disease management through various strategies. Suraj Nagwanshi | Smita Aher | Rishikesh Bachhav "Management of Diabetes Mellitus: A Review" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-6 , October 2021, URL: https://www.ijtsrd.com/papers/ijtsrd46348.pdf Paper URL : https://www.ijtsrd.com/pharmacy/other/46348/management-of-diabetes-mellitus-a-review/suraj-nagwanshi
Fasting and Caloric Restriction Show Promise for Reducing Type 2 Diabetes Bio...Premier Publishers
The global epidemic of type 2 diabetes (T2D) and its co-morbidities threatens to overwhelm public health services and urgent patient intervention is necessary. A review of mainly randomised controlled trials investigating the reduction of biochemical T2D risk markers through fasting or caloric restriction (CR) found that in T2D or where baseline fasting glucose or HbA1c were elevated, there were significant improvements in fasting glucose and HbA1c, while fasting insulin and insulin resistance may show improvement regardless of condition or baseline levels. There may, however, be ethnic differences, with a clear positive correlation found only in Caucasians. Intermittent CR (i.e. non-continuous periods of fasting) is at least as effective as isocaloric continuous CR, while CR of 400-800 kcal/day is possibly more effective than higher levels for reducing fasting glucose and HbA1c. Time restricted feeding also shows promise but there are few human studies. The findings suggest that the optimum regimen to reduce biochemical risk markers for T2D is an intermittent fasting programme employing a very low-calorie diet with the longest possible number of consecutive days of fasting. The addition of liquid meal replacements, low carbohydrate CR and supplementation of vitamin D, ω-3 PUFAs and L-carnitine may also be of benefit.
This Presentation is Briefly Discussing Diabetes in General,
Anti-Diabetic Venomous Animals and the Role of Naja Naja Snake Venom in The Treatment of it.
3. Overview of Diabetes Mellitus
Diabetes mellitus is a group of
metabolic diseases characterized by
chronic hyperglycaemia resulting
from defects in insulin secretion,
insulin action or both.
4. Criteria for diagnosis
Symptoms of DM and casual plasma
glucose conc. > 11.1mmol/L(200mg/dl) (10
for venous)
Fasting Plasma Glucose > 7.0mmol/L
(126mg/dl) (6.3 for venous and capillary)
2hr post load of glucose >11.1mmol/L
during an OGTT
5. Types of DM
1. Type 1 Diabetes Mellitus (T1DM):- β
cell destruction leading to absolute
insulin deficiency. Immune mediated,
idiopathic
2. Type 2 Diabetes Mellitus (T2DM):-
insulin resistance with relative insulin
deficiency
3. Other types
Gestational DM
6. Genetic defects of
◦ β cell function
◦ Insulin action
Diseases of the pancreas
Endocrinopathies
Infections
Drug or chemical induced
Genetic syndromes
Uncommon forms of immune related
7. TYPE 1 DM
Type 1 DM is the most common
endocrine metabolic disorder of
childhood and adolescence.
Autoimmune mechanisms are factors in
the genesis of T1DM.
• Most cases are primarily due to T-cell
mediated pancreatic islet β-cell
destruction.
8. Serological markers of an autoimmune
pathologic process, including islet cell,
glutamic acid decarboxylase (GAD), islet
antigen (IA)-2, IA-2b, or insulin
autoantibodies (IAAs), are present in 85–
90% of individuals when fasting
hyperglycaemia is detected
8
10. EPIDEMIOLOGY
T1DM accounts for about 10% of all diabetes,
affecting 1.4million in the USA and over 15million
in the world.
While it accounts for most cases of diabetes in
childhood, it is not limited to this age group; new
cases continue to occur in adult life and
approximately 50% of individuals with T1DM
present as adults.
11. The incidence of type 1 DM is highly
variable among different ethnic groups.
Girls and boys are almost equally affected
but there is a modest female preponderance
in some low risk populations (e.g the
Japanese).
There is no apparent correlation with
socioeconomic status.
12. Peaks of presentation occur in 2 age
groups: at 5-7 years of age and at the time
of puberty.
The first peak may correspond to the time
of increased exposure to the infectious
agents coincident with the beginning of
school;
13. The 2nd
peak may correspond to the
pubertal growth spurt induced by gonadal
steroids and the increased pubertal growth
hormone secretion( which antagonizes
insulin).
These possible cause-and-effect
relationships remain to be proved.
13
14. Morbidity and mortality stem from acute
metabolic derangement and long-term
complications (usually in adulthood) that
affect small and large vessels resulting in
retinopathy, nephropathy, neuropathy,
ischaemic heart disease and arterial
obstruction with gangrene of the
extremities.
15. The acute clinical manifestations are due to
hypoinsulinaemic hyperglycaemic
ketoacidosis.
Individuals with TIDM confront serious
lifestyle alteration that include an absolute
daily requirement for exogenous insulin,
the need to monitor their own glucose
level, and the need to pay attention to
dietary intake. 15
16. Predisposing Factors for T1DM
The major histo-compatibility complex on
chromosome 6 – greatest contribution
Viral infections: Congenital rubella
syndrome, Enteroviruses, Mumps virus.
Diet: Breast-feeding may lower the risk of
T1DM either directly or by delaying
exposure to cow’s milk protein.
17. Hygiene Hypothesis: Possible protective
role of infections. Lack of exposure to
childhood infections may somehow
increase an individual’s chances of
developing autoimmune diseases
including T1DM.
Psychologic stress
18. T2DM
Heterogenous disorder characterized by
peripheral resistance and failure of the β-cell to
keep up with increasing insulin demand.
These patients have relative rather than absolute
insulin deficiency.
Generally they are not ketosis prone, but
ketoacidosis may develop in some circumstances.
Aetiology is not known, but these patients do not
have autoimmune destruction of β-Cell nor do they
have any of the known causes of secondary
diabetes mellitus.
19. DKA: INTRODUCTION
Diabetic ketoacidosis (DKA) is a metabolic
derangement caused by the absolute or
relative deficiency of insulin
It is one of the most important causes of
mortality and severe morbidity in children
with diabetes, particularly at the time of first
diagnosis.
Early recognition and careful management
are essential if death and disability are to be
avoided
19
20. HISTORY
The first full description of diabetic
ketoacidosis is attributed to Julius
Dreschfeld, a German pathologist working in
Manchester, United Kingdom in 1886
The condition remained almost universally
fatal until the discovery of insulin in the
1920s;
20
21. Insulin was first isolated from the pancreas
in 1922 by Banting and Best.
The entity of cerebral oedema due to DKA
was described in 1936 by a team of doctors
from Philadelphia.
21
22. EPIDEMIOLOGY
Few data are available
In the United Kingdom national study,
60% of all cases occurred in patients with
known diabetes
In the USA, 25% of new cases of Type 1
DM present with ketoacidosis,
approximate incidence of 4 per 100,000
children annually.
22
23. 88% of patients first present in the children's
emergency room with Diabetic ketoacidosis
(DKA) (Ugochi Ibekwe et al, Federal Teaching
Hospital Abakaliki)
DKA has been found in the range of 7-80%
in newly diagnosed patients and 25-90% in
children who have already been diagnosed with
diabetes.
This high prevalence of DKA is attributed to
the lack of awareness among health workers
and the community at large (Adesiyan et al) 23
24. In FMC Keffi:
From January 2013 to May 2014, a total of
6 patients were admitted for DKA
5 females and 1 male
Age range: 8-11years (except the male,
3years 9months)
2 cases were admitted in May 2014
24
25. Sex: Although no difference in DKA rates
exists between the sexes at diagnosis and
during early childhood, adolescent girls with
diabetes are twice as likely to develop DKA
as adolescent boys.
Age:
– Preschool aged children are at greatest risk of
presenting with DKA because the diagnosis of
diabetes in children is often missed.
– Adolescents are more likely to develop DKA
after diagnosis of diabetes 25
26. PHYSIOLOGY
Insulin is a polypeptide containing two
chains of amino acids linked by disulfide
bridges
The net effect of the hormone is storage of
carbohydrate, protein, and fat. Therefore,
insulin is appropriately called the
“hormone of abundance”
26
27. Rapid (seconds)
Increased transport of glucose, amino acids, and K+
into
insulin-sensitive cells
Intermediate (minutes)
Stimulation of protein synthesis
Inhibition of protein degradation
Activation of glycolytic enzymes and glycogen
synthase
Inhibition of phosphorylase and gluconeogenic
enzymes
Delayed (hours)
Increase in mRNAs for lipogenic and other enzymes
Principal Actions of Insulin
27
28. Insulin inactivates liver phosphorylase
Increases the activity of the enzyme
glucokinase which causes the initial
phosphorylation of glucose after it diffuses
into the liver cells.
Increases the activity of glycogen
synthase
Insulin inhibits the action of hormone-
sensitive lipoprotein lipase 28
29. Adipose tissue
Increased glucose entry
Increased fatty acid synthesis
Increased glycerol phosphate synthesis
Increased triglyceride deposition
Inactivation of lipoprotein lipase
Inhibition of hormone-sensitive lipase
Increased K+
uptake
Effects of Insulin on Various Tissues
29
31. Decreased ketogenesis
Increased protein synthesis
Increased lipid synthesis
Decreased glucose output due to decreased
gluconeogenesis, increased glycogen
synthesis, and increased glycolysis
General
Increased cell growth
Liver
31
32. INFLUENCE OF FEEDING (HIGH INSULIN) OR OF
FASTING (LOW INSULIN) ON SOME METABOLIC
PROCESSES IN LIVER, MUSCLE AND ADIPOSE TISSUE
HIGH PLASMA INSULIN
(POSTPRANDIAL STATE)
LOW PLASMA INSULIN (FASTED
STATE)
Liver Glucose uptake Glucose production
Glycogen syntheses Glycogenolysis
Absence of gluconeogenesis Gluconeogenesis
Lipogenesis Absence of lipogenesis
Absence of ketogenesis Ketogenesis
Muscle Glucose uptake Absence of glucose uptake
Glucose oxidation Fatty acid and ketone oxidation
Glycogen synthesis Glycogenolysis
Protein synthesis Proteolysis and amino acid release
Adipose Tissue Glucose uptake Absence of glucose uptake
Lipid synthesis Lipolysis and fatty acid release
Triglyceride uptake Absence of triglyceride uptake 32
33. PATHOPHYSIOLOGY
Insulin deficiency exaggerates the normal
response to fasting: gluconeogenesis and
glycogenolysis.
Peripheral glucose uptake is impaired and
levels of the main counter-regulatory
hormones increase (glucagon, cortisol,
catecholamines, growth hormone).
A variety of metabolic consequences
follow. 33
34. Secondary to insulin deficiency and the action of
counter-regulatory hormones (glucagon), blood
glucose increases due to glycogenolysis and
gluconeogenesis, leading to hyperglycemia and
glucosuria.
Blood glucose levels rise above the renal threshold
for glucose reabsorption, causing an osmotic diuresis,
leading to waterwater & electrolyte loss.
In the absence of insulin activity the body fails to
utilize glucose as fuel and uses fats instead. This leads
to ketosis. 34
35. The excess of ketone bodies will cause metabolic
acidosis, the latter is also aggravated by lactic
acidosis caused by dehydration & poor tissue
perfusion.
Vomiting due to an ileus, plus increased
insensible water losses due to tachypnea will
worsen the state of dehydration.
Electrolyte abnormalities are secondary to their
loss in urine & trans-membrane alterations
following acidosis & osmotic diuresis.
35
36. Because of acidosis, K+
ions enter the circulation
leading to hyperkalemia, this is aggravated by
dehydration and renal failure.
Depending on the duration of DKA, serum K+
at
diagnosis may be high, normal or low, but the
intracellular K+
stores are always depleted.
Phosphate depletion will also take place due to
metabolic acidosis.
Na+
loss occurs secondary to the hyperosmotic
state & the osmotic diuresis. 36
37. The dehydration can lead to decreased
kidney perfusion and acute renal failure.
Accumulation of ketone bodies contributes
to the abdominal pain and vomiting.
The increasing acidosis leads to acidotic
breathing and acetone smell in the breath
and eventually causes impaired
consciousness and coma.
37
38. Fluid and electrolytes
Fluid losses are considerable, typically 3-10%
of body weight.
Most water is lost by osmotic diuresis, with
important contributions from hyperventilation
and vomiting.
The diuresis also leads to considerable urinary
losses of potassium, sodium, phosphate, and
magnesium ions 38
39. Ketoacidosis
Insulin inhibits the lipolytic action of cortisol
and growth hormone, so insulin deficiency
increases circulating levels of fatty acids.
These are oxidized in the liver, producing the
acidic ketone bodies: beta-hydroxybutyrate
and acetoacetate, from which acetone
spontaneously forms.
The resulting acidosis primarily is due to
circulating ketone bodies, with a smaller
contribution from excess fatty acids and lactic
acidosis, as a consequence of poor tissue
perfusion. 39
40. Absolute insulin deficiency OR
Stress, infection or insufficient insulin intake
Counter-regulatory hormones: Glucagon, Cortisol,
Catecholamines, GH
Lipolysis
FFA to liver
Ketogenesis
Alkali reserve
Acidosis
Lactate
Glucose
utilization
Proteolysis
Protein synthesis
Glycogenolysis
Gluconeogenic substrates
Gluconeogenesis
Hyperglycemia
Glucosuria (osmotic diuresis)
Loss of water and electrolytes
Dehydration
Impaired renal function
Hyperosmolarity
40
41. Clinical Presentation
Features of DKA are progressive.
Symptoms are aggravated by presence of some
precipitating factors.
Inter current infections
Drugs e.g steroids, thiazides, terbutaline,
dobutamine
Psychological stress
Trauma
Alcohol and drug abuse
Insulin omission in already diagnosed diabetics 41
43. Abdominal discomfort or pain
Nausea, vomiting
Dehydration- moderate to severe
Deep, heavy and rapid breathing-
Kussmaul’ s breathing
Fruity acetone breath
Lethargy
Altered mental state from disorientation to
coma 43
52. Cerebral Edema
Occurs in 0.5 – 1% of children.
Accounts for 90% of neurological
complications of DKA
Carries a high mortality risk – 70%.
Only about 15% recover without sequelae.
Typically occurs 6 – 10 hours after
initiation of treatment.
It often follows a period of clinical
improvement.
52
53. Mechanism not fully understood but few
theories-
Loss of cerebral autoregulation
Vasogenic mechanism of edema formation.
Cerebral ischemia
53
54. Risk factors
Younger age - < 5 years
Rapid rehydration
Prolonged duration of symptoms prior to
therapy
Administration of IV bicarbonate
High initial glucose concentration
Hypernatremia or persistent hyponatremia.
54
56. Diagnosis
Based on a single criterion:
Decorticate or decerebrate posture
Cranial nerve palsy – iii, iv, vi
Abnormal respiration
Abnormal verbal or motor response to pain
56
59. Treatment of DKA
DKA is an emergency; but, it is managed with
cautious urgency
Treatment of DKA requires frequent eyes-on,
hands-on and brain-on reassessment
It should never be “auto-pilot” or managed
from the call room
Team consultant must be informed
68. Fluid calculation
Deficit= estimated% dehydration x wt x 10
(mls)
Maintenance= wt x 100ml/kg (1st
10kg)
+50ml/kg (2nd
10kg)
+20ml/kg (subsequent kg)
Example; 20kg child, 10% dehydrated
Deficit= 10x 20 x10 = 2000 ml
Maintenance= 20 x 60= 1200 x2=2400/48hrs
Total fluids over 48hr= 4800ml @ 33dpm
69. Electrolyte replacement
Electrolyte depleted in DKA include; K+
,Na+
PO4
,
and Mg2+
Total body K+
always depleted in DKA (≈4-
6mmol/kg)
initial level of K+
may be low, normal or high
K⁺ Should not be started until shock is corrected
Requires ECG monitoring
70. Rate of infusion is usually 3mmol/kg/24hr
(max dose 0.5mmol/kg/hr)
Hypokalemia; give after initial fluid
resuscitation
20mmol/L
Eukalemia; at the time of insulin
introduction
40mmol/L (20 as KCl, 20 as KPO4)
71. Insulin
Insulin is required to reverse the metabolic
abnormalities by further decreasing blood
glucose and inhibiting ketone body
formation.
Only give when shock has been reversed
Usually started in the 2nd
hr of management
72. Recommended initial dose is 0.1U/kg/hr of
soluble insulin
Subcutaneous insulin 0.3U/kg stat, then
0.1U/kg/hr if iv access not possible: provided
good peripheral circulation
Insulin can be reduced to 0.05U/kg/hr (if pH
> 7.3, HCO3
-1
, rate of fall of glucose >
5mmo/L/hr)
If RBS falls to < 4mmol/L (give 2ml/kg of
10% DW bolus)
73. Insulin Therapy
10 units of short-acting Insulin with 0.9%saline into a
soluset/syringe pump to make up 100ml, producing a
concentration of 1U/10ml
E.g. a seven year old weighing 30kg requiring 0.1U/kg/hour
of insulin
0.1 x 30 = 3U/hour
Since 10ml=1U, then 3U/hour = 30ml/hour
60drops = 1ml
Hence 30 x 60 = 1800drops/hour (60mins =1hour)
30 drops/minute
74. Correction of acidosis
Usually autocorrected by IVF and insulin
administration ( improved GFR)
NaHCO3 is given cautiously if there is;
pH< 6.9
HCO3
-1
< 5mmol/L
Given empirically at dose of 1-2mmol/kg
over 1hr as infusion
75. Treat infections
Commonest precipitant of DKA
Usually started empirically until blood
culture is available
May include treatment for malaria,
pneumonia, meningitis etc as
appropriate
76. Monitoring treatment complications
Cerebral edema
Major cause of mortality
Complicated by early commencement of
insulin
Overzealous rehydration also a culprit
Also implicated is correction of acidosis
with NaHCO₃
Severe hyperglycemia with high
osmolality (Sosm>350 mOsm /L)
77. Treatment includes;
Reduction of IVF to ½ or 2/3rd
of maintenance
Elevate head 30 to the horizontal⁰
IV mannitol 0.5-1g/kg/dose 6-8hrly (iv furosemide as
adjunct)
IV 3% (hypertonic) saline 2-4ml/kg alternative
Hyperventilation
Dialysis
78. Hypoglycemia
Usually caused by high insulin doses/bolus
injections
Prevented by regular blood sugar monitoring
while patient is on insulin infusion
Corrected by giving 2-4ml/kg of iv 10% DW
bolus, continuing ivf 0.45% saline + 5% DW
(which may be increased to 10% DW)
Dose of insulin infusion may be reduced by
0.025U up to 0.5U/kg/hr
80. Monitoring
Neurological assessment: ½ -1hourly
Vital signs: Pulse rate, respiratory rate BP - hourly
Strict intake / output chart
Random blood sugar & urine/blood ketones hourly
Electrolytes: initially 2hourly. When K and Na are
normal and HCO > 15mmol/L 4-6 hourly₃⁻
81. Transition to subcutaneous insulin
When dehydration, acidosis and hyperglycemia
are corrected
Blood ketone levels are low (<1mmol/L)
Patient is tolerating orally, no longer vomiting
Target blood sugar before commencement 8.3-
13.8 mmol/L
82. Dose; 0.5-0.7U/kg/dose of soluble insulin
8 hourly
Dose up to 1.0U/kg/day of mixtard on
discharge
< 30kg: 0.3U/kg/day; 2/3rd
AM,1/3rd
PM
> 30kg: 0.6U/kg/day; 2/3rd
AM, 1/3rd
PM
Stop insulin infusion ½ to 1hour after
commencement of subcutaneous injection
83. Counseling for discharge
Treatment is lifelong
Educating patient and family members on:
Basic pathophysiology of DM
Importance of adequate control to avoid
complications
Survival skills:
How to check/monitor blood glucose
Monitor urine glucose and ketones
Preparation and injection of insulin
How to recognize hypoglycemia and hyperglycemia
How to plan meals
84. Long term monitoring
HbAIC; Normal < 6%:
In diabetics;
6-7.9: good control
8.0-9.9: fair control
>10: poor control
Early treatment of infections/injuries
Growth monitoring
88. Prevention
General Health Promotion: enlightenment
Specific prevention
Early diagnosis and treatment
Limitation of disability
Rehabilitation
88
89. Conclusion
DKA is a common complication of
paediatric diabetes melitus
It carries significant risk of death and/or
morbidity especially with delayed
treatment
High index of suspicion is required for
early detection and treatment
Treatment is done with cautious urgency in
order to forestall complications of 89
90. References
Nelson Textbook of Paediatrics, 19th
Edition
Medscape: Paediatric Diabetes Mellitus
Paediatric Management of Paediatric
DKA; Guidline No. 13; 3rd
Edition by Dr.
Carrihill and Greening
BSPED Recommended DKA Guidelines
2013
Endocrinology update 2012/2013 90